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Partridge and Eric J. EnemarkAbstractLegend. TheDEAD-boxRNAhelicaseDDX3X is frequently
mutated in pediatric medulloblastoma. A subset of mutants is
severely defective for RNA-stimulated ATP hydrolysis and
also in complementation of Schizosaccharomyces pombe
ded1 temperature-sensitive strains. RNA-stimulated ATP
hydrolysis critically relies on a loop structure that is shown to
dynamically interact with nucleotide by crystallography and
by solution NMR spectroscopy.The DEAD-box RNA helicase DDX3X is frequently
mutated in pediatric medulloblastoma. We dissect how
these mutants affect DDX3X function with structural,
biochemical, and genetic experiments. We identify an
N-terminal extension (“ATP-binding loop”, ABL) that is
critical for the stimulation of ATP hydrolysis by RNA.
We present crystal structures suggesting that the ABL
interacts dynamically with ATP and confirming that the
interaction occurs in solution by NMR chemical shift
perturbation and isothermal titration calorimetry.
DEAD-box helicases require interaction between two
conserved RecA-like helicase domains, D1 and D2 for
function. We use NMR chemical shift perturbation to
show that DDX3X interacts specifically with double-
stranded RNA through its D1 domain, with contact
mediated by residues G302 and G325. Mutants of
these residues, G302V and G325E, are associated
with pediatric medulloblastoma. These mutants are
defective in RNA-stimulated ATP hydrolysis. We show
that DDX3X complements the growth defect in a ded1
temperature-sensitive strain of Schizosaccharomyces
pombe, but the cancer-associated mutants G302V
and G325E do not complement and exhibit protein
expression defects. Taken together, our results
suggest that impaired translation of important mRNA
targets by mutant DDX3X represents a key step in the
development of medulloblastoma.
© 2015 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).s an open access article under the CC BY license
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1780 Cancer-Associated Mutants of DDX3XIntroductionMedulloblastoma is the most common malignant
childhood brain tumor. It has been divided into four
subgroups based upon transcriptional analysis of
primary tumors: WNT, SHH, Group 3, and Group 4
[1]. Although the molecular basis of each subgroup
differs, all patients with medulloblastoma neverthe-
less receive the same combination therapy of
surgery, radiation, and chemotherapy [2]. Approxi-
mately 70% of patients are cured, but their quality of
life is severely compromised. Subgroup-specific
treatments could potentially increase cure rates
and/or increase the quality of life for medulloblasto-
ma survivors by decreasing side effects that include
long-term neurocognitive deficits [3]. The St. Jude
Washington University Pediatric Cancer Genome
Project (PCGP) [4] performed whole genome se-
quencing of several medulloblastoma tumors in each
subgroup [2] and demonstrated a strong association
between mutation of the protein DDX3X and specific
subgroups of medulloblastoma, particularly the WNT
subgroup [2]. Other studies have also linked DDX3X
mutation to medulloblastoma [5–7]. Of nine DDX3X
mutants identified by the PCGP, eight were associ-
ated with medulloblastoma [2], and one (R351W)
was identified in an infant acute lymphoblastic
leukemia (James Downing and Jinghui Zhang,
personal communication).
DDX3X is a member of a large family of RNA
helicases known as “DEAD-box” helicases [8,9].
This name is derived from the conserved Asp-Glu-A-
la-Asp sequence motif [10] in “helicase motif” II [11]
that contains the catalytic base for ATP hydrolysis.
The DEAD-box helicases belong to a larger group of
helicases known as “Super Family 2”, which is
similar to the “Super Family 1” group of helicases.
Both of these super families (reviewed in Refs. [12–
14]) are defined by conserved helicase motifs [11]
that reside on adjacent RecA-like domains (D1 and
D2) connected by a linker (Fig. 1a). Interdomain
movements generated by ATP binding and hydroly-
sis at the D1–D2 interface are expected to drive
manipulation of substrate nucleic acid [12]. For DNA
helicases, such as the Super Family 1 helicases
PcrA [15] and Dda [16] or the Super Family 2
helicase RecQ [17], a robust in vitro strand-displace-
ment activity is observed with synthetic DNA
substrates [18–21]. In contrast, DEAD-box helicases
often do not display an in vitro unwinding activity [22],
and when an unwinding activity is observed, the
duplex region is generally not longer than 10 base
pairs [23], suggesting that DEAD-box helicases
might serve more of a remodeling function [22,24]
than a strand-displacement function.
The DEAD-box helicase family is characterized by
additional specialized sequence motifs [8]. These
include the Q-motif [25], a conserved phenylalanine
(“F-motif”) [25], motif Ib (“GG motif”) [26], and motifIVa (“QxxR motif”) [27]. Some of the helicase motif
residues are involved in ATP binding or hydrolysis,
while others bind substrate nucleic acid [8]. DDX3X
is highly similar to the Ded1 proteins of Saccharo-
myces cerevisiae and Schizosaccharomyces
pombe (SpDed1), as well as to Drosophila melano-
gaster Belle and Vasa (DmVasa) in sequence (see
Fig. S1b) [28], and the DDX3X D1–D2 structure
closely resembles the Vasa D1–D2 structure [29,30].
The likely roles of the conserved sequence motif
residues in DDX3X are illustrated in the crystal
structure ofDmVasa in complex with single-stranded
RNA (ssRNA) and an ATP analog [30]. The structure
demonstrates how Vasa binds RNA and ATP in a
conformation that appears poised for ATP hydrolysis
[30], termed the “closed conformation” [31].
Of the nine DDX3X mutations identified by the
PCGP, eight are in D1 (Fig. 1a and Fig. S1a and b),
suggesting that DDX3X function is more sensitive to
mutation in D1 than in D2. Many of the mutations are
located in or adjacent to the helicase sequence
motifs, suggesting that the mutations may disrupt
fundamental activities. Three (T275M, G302V, and
G325E) are in helicase motifs implicated in binding
RNA [8]. These motifs presumably interact with one
strand of RNA in the manner observed in the crystal
structure of Vasa [30], which shows that main-chain
amides in each of the three corresponding regions
directly contact the backbone of one ssRNA strand.
Although side-chain mutagenesis does not directly
alter interactions with the main chain, these muta-
tions could disrupt binding to the RNA strand by
altering the main-chain structure itself or by sterically
preventing the proximity needed for interaction. In
order to remodel RNA secondary structure, a
DEAD-box helicase may also interact with an
opposing RNA strand. A good candidate for such
interactions is the region described as motif IIa [32].
Although this motif does not have a well-conserved
sequence, the structural element is often observed
to interact with the complementary strand of nucleic
acid [32]. Interestingly, three of the DDX3X muta-
tions cluster directly after motif II (R351W, L353F,
and D354V). Thus, if DDX3X binds double-stranded
RNA (dsRNA), three of the mutations (T275M,
G302V, and G325E) potentially alter binding to one
RNA strand, and three of the mutations (R351W,
L353F, and D354V) potentially alter binding to the
complementary RNA strand.
DDX3X has been implicated in many aspects of
RNA processing [33–35], including the positive
regulation of translation of transcripts with complex
untranslated region (UTR) sequences [36–38].
DDX3X has been implicated in binding mRNAs
containing the TAR (trans-activation response ele-
ment) motif of HIV (human immunodeficiency virus)
and in facilitating their translation [37]. The Ded1
proteins of S. cerevisiae [39] and S. pombe [40] are
essential proteins that share a strong level of
1781Cancer-Associated Mutants of DDX3Xsequence homology with DDX3X. In fission yeast,
Ded1 is required for translation, particularly for
mRNAs with complex UTRs [41]. Thus, in addition
to a strong level of sequence homology (Fig. S1b),
SpDed1 appears to share functional homology with
DDX3X and therefore may be a useful model to
elucidate the biological and biochemical functions of
DDX3X and the cancer-associated mutants.
In this study, we characterize the properties of
DDX3X and DDX3X mutants identified in pediatric
cancer. We show that the ATPase activity of DDX3X is
specifically stimulated by a hybrid dsRNA/ssRNA
substrate but is not stimulated by blunt dsRNA or by
ssRNA. Stimulation of the ATPase activity relies on the
presence of a DDX3X structural loop N-terminal to the
first RecA domain that we define as the “ATP-binding
loop” (ABL). We show that the ABL is a flexible loop
that sits on top of the bound nucleotide in the crystal
structure of medulloblastoma mutant D354V, and we
confirm the interaction between the ABL and ATP for
wild-type DDX3X in solution by NMR chemical shift
perturbation (CSP) and by isothermal titration calorim-
etry (ITC). We show that DDX3X residues G302 and
G325 are involved in dsRNA binding and that the
pediatric medulloblastoma mutants G302V and
G325E are severely defective for RNA-stimulated
ATPase activity. In contrast, the pediatric medulloblas-
toma mutant D354V exhibits normal RNA-stimulated
ATPase activity, and L353F shows only a minor
decrease in this ATPase activity. We show that
DDX3X and medulloblastoma mutants L353F and
D354V can complement temperature-sensitive ded1
alleles in fission yeast. In contrast, the medulloblasto-
ma mutants G302V and G325E cannot complement
ded1 and exhibit protein expression defects. We
suggest that some of the DDX3X mutants identified
in pediatric medulloblastoma have a defective RNA-s-
timulated ATPase activity that impairs translation of
critical cellular regulators and thus contributes to
medulloblastoma.Results
We first sought to identify a minimal ATPase active
construct of wild-type DDX3X that would be amena-
ble to crystallographic and biochemical investiga-
tion. A crystal structure of a DDX3X construct
comprising the minimal RecA domains D1 and D2
(168–582) has previously been reported [29]. How-
ever, this protein was reported to lack RNA-
stimulated ATPase activity [29]. We noted that the
N-terminus of the construct corresponds to the
minimal N-terminus of the first RecA fold, similar to
the native N-terminus of the DEAD-box helicase
eIF4A (Fig. S1b) [27]. In contrast, the crystal
structure of the more closely related Vasa helicase
included additional N-terminal residues that interact
with a bound ATP analog [30], and this proteinconstruct had ATPase activity [30]. We found that a
DDX3X construct with a similar N-terminal extension
(135–582) had an ATPase activity that was stimu-
lated by RNA (Fig. 1b and Fig. S2a and b) while
DDX3X (168–582) did not exhibit significant RNA-
stimulated ATPase activity, as reported previously
[29]. Following this identification, we generated
DDX3X (135–582) expression reagents for each of
the PCGP-identified mutants. Several of the mutant
DDX3X (135–582) proteins were isolated in good
yield, namely, wild type, G302V, G325E, L353F, and
D354V. The other DDX3X mutants appeared to
generate exclusively insoluble protein during bacte-
rial expression (data not shown).
ATPase activity is specifically stimulated by
hybrid dsRNA/ssRNA
While none of the DDX3X (135–582) proteins
showed significant basal ATPase activity, wild type,
L353F, and D354V had substantial ATPase activity in
the presence of a palindromic RNA substrate consist-
ing of 10-mer dsRNA with 20-mer single-stranded
5′-overhangs (Fig. 1b and Fig. S2a and b). The
ATPase activity is time dependent (Fig. 1b) and is
protein concentration dependent (Fig. S2b). All mu-
tants, except D354V, showed a significant decrease in
ATP hydrolysis rate. The G302V and G325E mutants
were especially defective, exhibiting extremely low
RNA-stimulated ATPase activities (Fig. 1b and Fig.
S2a and b). For the proteins that showATPase activity,
this activity was not stimulated by 14-mer blunt duplex
RNA or by 10-mer oligo-rU ssRNA (Fig. S2a),
suggesting that DDX3X is specialized for a dsRNA/
ssRNA hybrid substrate. The requirement for an
ssRNA tail to stimulate ATPase activity is consistent
with several other DEAD-box helicases [42,43].
DDX3X D354V crystal structure reveals an ABL
To structurally characterize the role of the N-ter-
minal extension in enabling ATPase activity, we
extensively screened each DDX3X protein construct
for crystallization and obtained crystals for mutant
D354V (135–582). Crystals grew in the presence of
ADP and sodium/potassium phosphate, and the
structure was solved to 3.2 Å resolution (Fig. 1c;
Figs. S3 and S4 and Table S1). The D354V mutation
is at the center of the D1–D2 interface possibly
stabilizing the two domains to facilitate crystallization
of this mutant. The individual RecA domains are very
similar in structure to those in the previously reported
structure of DDX3X (168–582) [29] (D1 168–246 and
263–404 Cα RMSD: 0.52 Å; D2 414–576 RMSD:
1.46 Å). Hence, the D354V mutation does not
significantly alter the structure of D1 or D2. The D1
and D2 domains in the D354V structure have a
different relative orientation than the previously
published structure of DDX3X (168–582) [29]. In a
1782 Cancer-Associated Mutants of DDX3XD1-based alignment of the two structures, the D2
center-of-mass positions are separated by 44 Å,
and the D2 domains are rotated by approximately(a)
(b)
(c)
Fig. 1 (legend o180°. Both DDX3X structures represent “open
conformations” rather than the “closed conforma-
tion” observed in the DmVasa structure [30] (Fig.n next page)
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mation highly similar to that observed in Vasa in
catalyzing ATP hydrolysis. Thus, although the
D354V mutation appears to stabilize a specific
interdomain conformation for crystallization, this
conformation is not locked because D354V is able
to catalyze ATP hydrolysis (Fig. 1b).
The structure reveals that part (residues 152–
160) of the N-terminal extension that is necessary
for RNA-stimulated ATP hydrolysis (see Fig. 1b)
appears to have a role in binding ATP, and we shall
refer to it as the ABL. Most of the ABL forms a
similar structure to the N-terminal extension of
Vasa, which has been implicated in ATP binding
[30], but the DDX3X residues N-terminal to L146
are directed differently (Fig. S3a). The extension
consists of a short α-helix with a conserved
phenylalanine (F151) that projects into a hydro-
phobic pocket formed by L197, Y291, and L150 and
the aliphatic portion of the K288 and E147 side
chains (Fig. S5a). Vasa F215 similarly projects into
a hydrophobic pocket formed by the aliphatic
portion of K262, F343, and I214 and the aliphatic
portion of K340 and A211 (Fig. S5b). This phenyl-
alanine and the hydrophobic pocket residues are
also conserved in the sequence of fission yeast
Ded1 (Fig. S1b, yellow arrow), suggesting that this
interaction is an important feature of this subgroup
of DEAD-box helicases. Although the loop between
this helix and the start of the first RecA-like domain
(corresponding to DDX3X amino acids 152–168) is
well ordered in the Vasa structure with observed
interactions with the AMP-PNP molecule [30], this
loop is more weakly ordered in DDX3X with
elevated B-factors. Due to limited side-chain
density, part of the region has been modeled as
polyalanine. The main chain appears to interact
with the sugar of the ADP molecule, but specific
residue interactions cannot be assigned from the
present crystal structure.
The ABL enhances DDX3X affinity for ATP
To determine the role of the ABL in binding ATP,
we determined the equilibrium dissociation con-
stants (Kd) for the binding of ATP-γS to DDX3XFig. 1. The domain architecture of DDX3X. (a) Two RecA
C-terminal extensions (dark blue and red, respectively). An N-
The positions of cancer-associated mutations are noted abov
3 μM DDX3X and its cancer-associated mutants in the pres
(DDX3X 135–582), wild type, D354V, and L353F all showed s
duplex RNA (1 μM duplex). The same proteins had negligible A
ssRNA or blunt duplex RNA (Fig. S2a). In contrast, the G302V
mean and standard deviation of two independent experiments
protein was determined as the slope (nanomoles of phosphate
Crystal structure of DDX3X (135–582) D354V. The bound ADP
nucleotide is shown in magenta. Domain D1 is shown in
PCGP-identified mutation positions are shown in blue with
Co-crystallized phosphate ions are shown in a ball-and-stick r(135–582) and to DDX3X-no-ABL (168–582) by
ITC. The dissociation constants reveal that the
protein lacking the ABL (Kd = 202 ± 15 μM) binds
with a 3-fold weaker affinity than the protein with the
ABL (Kd = 62 ± 6 μM) (Fig. 2a), suggesting a
significant and direct role for the ABL in binding
ATP.
NMR CSP confirms ABL:ATP interaction
We used NMR CSP to confirm direct interaction
between the ABL and ATP suggested by the crystal
structure. As the D1–D2 protein (53 kDa) is too large
to analyze by NMR CSP, we chose to analyze D1 in
isolation (33 kDa) because the interactions between
DDX3X and ADP exclusively reside in D1 in our
crystal structure of DDX3X mutant D354V. First, we
confirmed that wild-type D1 (135–407) in isolation is
similarly structured to the D1 portion of D354V (135–
582) and that it interacts equivalently with ATP
analog as with ADP by determining a crystal
structure of wild-type DDX3X D1 in complex with
AMP-PNP to 2.3 Å resolution (Figs. S6 and S7 and
Table S1). The structure consists of three monomers
in the asymmetric unit, all very similar to the D1
portion of the D354V D1–D2 structure (RMSD: 0.71,
0.72, and 0.76 Å for the three crystallographically
unique monomer Cα positions). Each monomer is
bound to a nucleotide modeled as ADP because the
γ-phosphate of the AMP-PNP molecule is not
observed in the electron density. Similar to the D1–
D2 D354V crystal structure, the ABL is weakly
ordered and has only been assigned for one of the
monomers. For this monomer, the ABL is positioned
consistently as in the D354V structure. Thus, this
crystal structure indicates that the D1 structure and
its interaction with nucleotide are not affected by
removal of D2. Next, we measured a transverse
relaxation optimized spectroscopy (TROSY) spec-
trum for this D1 construct (Fig. 2b). We assigned the
backbone resonances in the well-dispersed 1H-15N
TROSY spectrum of DDX3X (135–407) with 90% of
the backbone resonances assigned without ambi-
guity by conventional triple-resonance TROSY-
based techniques for large biomolecules (Table
S2). The Cα deviations from random-coil values-like domains (cyan and light orange) flanked by N- and
terminal ABL described in this study is shown in magenta.
e. (b) Time-dependent RNA-stimulated ATPase activity of
ence of 2 mM ATP. For DDX3X constructs with the ABL
ignificant ATPase activity in the presence of 1 μg 5′-tailed
TPase activity in the absence of RNA or in the presence of
and G325E mutants are defective in ATPase activity. The
for each protein are shown. The enzymatic activity of each
released per minute) following linear regression (right). (c)
nucleotide is shown in stick. The ABL that sits on top of the
cyan, and domain D2 is depicted in orange. All the
the side chains of the D354V structure shown in stick.
epresentation.
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confirm that the solution conformation of D1 is very
similar to the crystal structure.0.6 
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1785Cancer-Associated Mutants of DDX3Xthe presence of the ATP analog, ATP-γS (Fig. 2b,
orange spectrum). Several backbone amides in the
binding pocket were in slow exchange in the NMR
spectrum, and thus, this spectrum was reassigned.
These experiments confirmed a key role for the ABL
in ATP interaction by showing strong CSPs in the
ABL upon binding ATP-γS. The CSP magnitudes in
the ABL were comparable to those in well-estab-
lished ATP-binding regions, namely, the Q-motif and
motif I (Fig. 2c and d). When mapped onto the
structure of D1, the CSPs correlate with the binding
region of nucleotide in the crystal structures (Fig. 2c).
The backbone amide resonances of three residues,
G227, S228, and G229, part of motif I, close to the
ATP-γS-binding site (Fig. 2c), were not observed in the
free spectrum or in the ATP-γS-bound form, suggest-
ing that this loop region in helicase motif I undergoes
motion in the millisecond-to-second timescale. Even
ATP-γS binding to this region does not stabilize the
loop, and therefore, the dynamics of this loop could be
functionally important in ATP binding and/or hydrolysis.
Additional, smaller shifts were observed in motifs Ia, II,
and III upon binding ATP-γS. None of the DDX3X D1
residues associated with medulloblastoma by the
PCGP [2] or by other studies [6,7] was significantly
shifted upon binding ATP-γS, indicating that the
residues associated with cancer mutants are not
directly involved in ATP binding.
NMR CSP shows DDX3X D1 binds dsRNA
differently than ssRNA and DNA
Because ATP hydrolysis was exclusively stimu-
lated by a dsRNA/ssRNA hybrid substrate, we used
NMR CSP experiments to deconvolute and localize
the interactions with each form of nucleic acid. For
these experiments, we used the same labeled D1
construct as in the ATP-γS experiments. Unfortu-
nately, we found that D2 could not be concentrated
to the level needed for the NMR experiments without
including high salt concentrations, consistent with a
previous report [44]. High salt concentrations are
incompatible with nucleic acid binding experiments
by NMR CSP, and as a result, the experiments were
carried out exclusively with D1. NMR spectra were
measured for D1 in combination with ssRNA and
dsRNA or DNA substrates (Fig. 3 and Fig. S8). Large
CSPswere observed uniquely upon addition of dsRNA
to D1 (Fig. 3b and c). In contrast, only minimal CSPs orFig. 2. DDX3X D1 interaction with ATP analog in solution.
were measured by titrating 2.5 μMATP-γS into 90 μM solutions
ABL (168–582; right). The determined dissociation constants r
3-fold tighter than the construct lacking the ABL (202 ± 15 μM
superimposed with the same in the presence of ATP-γS in the
ATP-γS complex are mapped onto the crystal structure of D1 s
from 0.06 to 0.6 ppm. The bound AMP-PNP molecule is sho
residue positions are labeled. (d) CSP values for the D1:ATP-γ
the ABL, the Q-motif, and motif I.peak broadening was observed upon addition of
double-stranded DNA (Fig. S8a). This observation is
consistent with previous reports that DEAD-box
helicases specifically bind A-form substrates and do
not bind to the B-form structure of double-stranded
DNA [9]. Upon addition of single-stranded DNA (Fig.
S8b) or ssRNA (Fig. 3a) to D1, the CSPs observed
were smaller than the CSPs after addition of dsRNA
andwere not confined to specific regions of the protein,
suggesting a less specific mode of interaction, such as
an overall electrostatic interaction between D1 and
these substrates. Taken together, the CSP experi-
ments indicate that DDX3X D1 is specialized for
binding dsRNA. When ATP-γS was added to the D1:
dsRNA complex, the CSPs were confined to residues
that shifted upon binding ATP-γS in the absence of
RNA (Fig. S8e), suggesting that the mode of dsRNA
binding was not significantly different after ATP
binding, consistent with a requirement for both D1
and D2 to generate ATP-dependent changes in RNA
interaction.
Comparison of the 1H-15N TROSY spectrum of D1
with that of the two-domain construct, 52.6 kDa,
DDX3X (135–582) showed that the conformation of
D1 is similar in both constructs (Fig. S8f). The D1
resonances that shift upon binding nucleic acid
remain unshifted in the spectra of free D1 and free
D1–D2, suggesting that the observed binding for D1
in isolation is also possible for the two-domain
protein. None of the surface residues of D1 showed
significant CSP in the D1–D2 protein, suggesting
that the orientation of the two domains is flexible in
solution, perhaps contributing to the difficulties in
crystallizing most of the D1–D2 DDX3X constructs.
Such flexibility is not surprising because interdomain
motion is expected to be necessary to generate
unwinding or remodeling activities.
The strongest peak shift in D1 upon binding
dsRNA corresponds to G325 (in helicase motif Ic)
(Fig. 3b–d). Residue G302 (motif Ib) is also clearly
shifted (Fig. 3c). These shifts suggest that G302 and
G325 have key roles in the interaction with dsRNA.
Strikingly, the ATP-binding region of D1 was also a
prominent region of CSP in the presence of dsRNA
(Fig. 3d). Although the protein is not expected to
catalyze ATP hydrolysis in the absence of critical
residues on D2 such as motif VI [8], the CSP in the
ATP-binding region of D1 in the presence of dsRNA
is consistent with dsRNA inducing conformational(a) The ABL enhances DDX3X affinity for ATP. Isotherms
of DDX3X either with the ABL (135–582; left) or lacking the
evealed that the construct with the ABL (62 ± 6 μM) binds
). (b) 1H-15N TROSY spectrum of the DDX3X D1 (in black)
molar ratio of 1:5 (in orange). (c) CSP values for the D1:
hown in loop representation in shades of orange for values
wn in stick representation. The ABL, Q-motif, and motif I
S complex versus residue number. The largest shifts are in
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Fig. 3. DDX3X D1 interaction with nucleic acids in solution. (a) Superposition of the 1H-15N TROSY spectra of DDX3X D1
(in black) with the same in the presence of ssRNA (in green) in themolar ratio of 1:1.2. (b) Superposition of the 1H-15N TROSY
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Electrophoreticmobility shift assays show that theG302Vmutant that is severely defective inRNA-stimulated ATPase activity
is also defective in binding dsRNA. The mean and standard deviation of three independent binding experiments with 40 nM
blunt duplex RNA are shown for each protein. Successive mean data points are connected by linear segments.
Representative EMSA gel images are provided in Fig. S9.
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1787Cancer-Associated Mutants of DDX3Xchanges at the ATP-binding site and could contrib-
ute in part to the stimulation of ATPase activity by
tailed dsRNA.
The cancer-associated mutants of DDX3X (135–
582) were investigated for binding to the same dsRNA
substrate of the NMR experiments by electrophoresis
mobility shift assays (EMSAs) to evaluate the
identified interactions in the D1–D2 protein (Fig. 3e
and Fig. S9). The L353F and D354Vmutants showed
very minor defects in binding the dsRNA substrate. In
contrast, the G302V mutant was significantly defec-
tive in binding the blunt dsRNA probe. Interestingly,
G325E showed no defect in binding this blunt RNA
substrate despite the strong conservation of glycine at
this position in DEAD-box helicase motif Ic (Fig. S1b).
Although the strong CSP for G325 indicates that this
residue intimately associates with dsRNA, the glycine
itself is not needed to bind dsRNA. Theglycine instead
appears to play a much stronger role in generating
RNA-stimulated ATP hydrolysis as shown by the
severely defective G325E mutant (Fig. 1b). The
conservation of the glycine is not likely specialized
for a backbone structural requirement because the
crystal structure of D354V shows that G325 is at the
start of an α-helix in a conformation allowable for any
residue (phi/psi = −54/−52).
DDX3X:dsRNA model
The CSPs that resulted from binding dsRNA were
evaluated for compatibility with the dsRNA mole-
cules of existing RNA helicase:dsRNA co-crystal
structures. No crystal structures are available to
show how D1 of a DEAD-box helicase binds dsRNA.
In the D354V crystal structure, residues G302 and
G325, in RNA-binding motifs Ib and Ic [8], are
observed to interact with co-crystallized phosphate
ions that are positioned similar to phosphates in the
RNA backbone of the aligned structure of DmVasa
[30] (Fig. S10), reinforcing the likelihood that DDX3X
interacts with RNA similar to Vasa. We investigated
three related scenarios for their fit to the NMR CSP
data: (1) D1 of the DEAD-box helicase Vasa bound
to ssRNA [30], (2) D1 of the DECH-box helicase
RIG-I bound to dsRNA [45,46], and (3) D2 of the
DEAD-box helicase Mss116p bound to dsRNA [9].
Mss116p D2 was used based on the previously
identified relationships of D1 and D2 for nucleic acid
binding [47] and also because the dsRNA substrate
of the CSP experiment was identical with that
present in the Mss116p D2:dsRNA crystal structure.
Specifically, DDX3X residues 274–277 (motif Ia),
301–304 (motif Ib), and 323–326 (motif Ic) were
used as a reference to align the RNA-binding regions
of the other structures followed by inspection of the
interactions between each protein and RNA and how
the positioned RNA agreed with the DDX3X D1:
dsRNA CSP data. We especially focused on multiple
RNA-binding interactions that involve main-chainamides that are likely to be consistent among all the
proteins and not subject to side-chain differences.
We first aligned residues 326–329, 353–356, and 375–
378 of DmVasa bound to ssRNA [30] (Fig. S11a) to
provide a benchmark for binding one strand. RIG-I
belongs to the DECH-box family of RNA helicases that
is closely related to the DEAD-box helicase family [48].
The RIG-I:dsRNA structure [45] was aligned based on
residues 298–301, 325–328, and 347–350 (Fig.
S11b). To align Mss116p D2 with DDX3X, we first
performed an overall alignment of the RecA folds to
identify the structurally equivalent residues, which
were then used to optimize the alignment of the
RNA-binding regions. Mss116p D2 residues 381–384
(motif IV), 407–410 (motif IVa), and 433–436 (motif V)
were aligned with the DDX3X residues described
above (Fig. S11c).
The residues that align with DDX3X R276 (motif
Ia) and G302 (motif Ib) show consistent interactions
between main-chain amides and sequential RNA
phosphates for all structures (Fig. S11a–c). In
contrast, the residues that align with motif Ic
(including DDX3X G325) showed significant differ-
ences in the structure of Vasa bound to ssRNA
versus the dsRNA-bound structures. In Vasa, the
residues that align with DDX3X 323–326 form
significant interactions with the RNA backbone,
while the corresponding atoms in the dsRNA-
bound structures are too distant to interact with
the same RNA nucleotide. As noted previously
[30], this region of the RNA strand deviates from an
idealized A-form trajectory and precludes an
idealized A-form dsRNA structure. Thus, in order
to interact with dsRNA, the residues of motif Ic,
such as G325, would need to move more exten-
sively than the RNA-binding residues in motifs Ia
and Ib. Our CSP data are fully consistent with this
scenario because the largest shifts occur upon
binding dsRNA and are located in motif Ic at residues
G325 and G326.
Among the candidate alignments, we selected the
dsRNA of the Mss116p D2:dsRNA complex [9] as
the best qualitative fit to the CSP data (Fig. 4a). The
resulting dsRNA position was found to align well with
the regions of DDX3X that exhibited the largest
CSPs for dsRNA: motifs Ia, Ib, Ic, II, and IIa and
helices α9 and α10, as well as the start of α11
(Fig. 4a). The superimposed Vasa D1–D2 model
showed significant steric clashes between D2 and
the modeled dsRNA (Fig. 4b), consistent with the
previous mechanistic suggestion that D1 and D2
cannot simultaneously bind the same dsRNA mole-
cule in the closed conformation [9]. The binding
model suggests that most of the DDX3X D1:dsRNA
interactions would involve the sugar-phosphate
backbone of one strand of RNA, but the region
around motif IIa might interact directly with RNA
bases in the dsRNA minor groove (Fig. 4a) or with
the complementary strand.
(a)
(b)
DDX3X D1:dsRNA CSP
Mss116p:dsRNA (PDB: 4DB2)
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Fig. 4. DDX3XD1:dsRNA binding model. (a) Orthogonal views of the DDX3X D1:dsRNAmodel based on the CSPs and
alignment of Mss116p D2:dsRNA [9]. The superposition was by least-squares alignment of DDX3X 274–277 (motif Ia),
301–304 (motif Ib), and 323–326 (motif Ic) with Mss116p residues 381–384 (motif IV), 407–410 (motif IVa), and 433–436
(motif V). DDX3X is shown in cyan with CSP in the presence of dsRNA in shades of red. The Mss116p dsRNA is shown in
yellow/yellow-orange. The dsRNA model aligns well with the regions of CSP at the right side of the molecule (right panel).
Other prominent regions of CSP in the presence of dsRNA are at the left side of the molecule in the ATP-binding site. The
ADP molecule of DDX3X is shown in green stick to highlight the region. These shifts are consistent with dsRNA inducing a
change in the ATP-binding site and could contribute to RNA-stimulated ATP hydrolysis. (b) The Vasa:ssRNA structure
(PDB ID: 2DB3) [30] superimposed on the DDX3X D1:dsRNA model in (a) with Vasa D1 shown in light blue and Vasa D2
shown in dark blue. D2 shows significant steric clashes with the modeled dsRNA (red circles), suggesting that the two
domains are not mutually compatible with binding the same dsRNA, consistent with Mss116p [9].
1788 Cancer-Associated Mutants of DDX3XDDX3X complements a temperature-sensitive
ded1 allele in S. pombe
We screened the functional consequences of the
PCGP mutations in a fission yeast complementationassay. Ded1, the fission yeast ortholog of DDX3X, is
encoded by an essential gene [40]. We first tested
whether expression of DDX3X could complement for
viability of the fission yeast ded1-1D5 thermosensitive
mutant [41] at restrictive temperature. We found that
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Fig. 5. DDX3X functionally complements SpDed1. (a)
Complementation of the cold-sensitive ded1-61 strain by
expression of the DDX3X mutant plasmids was examined
in a serial dilution assay. The Walker-A mutant, K230A,
was the most defective and impacted growth at the
permissive temperature of 33 °C. Growth of strains
expressing the mutants A222P, G302V, and G325E was
significantly impaired at the restrictive temperature
(25 °C). (b) Growth defects of affected strains correlate
with lower expression of Cig2 protein following incubation
at low temperature (20 °C) according to immunoblotting of
the HA-epitope-tagged Cig2. (c) The decrease in expres-
sion is not due to lower mRNA levels as indicated by
quantitative real-time PCR of cig2+ transcripts normalized
to adh1+.
1789Cancer-Associated Mutants of DDX3Xepisomal expression of either wild-type SpDed1 or
HsDDX3X rescued the temperature-sensitive
growth defect of ded1-1D5 cells (Fig. S12a). The
level of vector-expressed Ded1 was similar to
endogenous Ded1 based upon immunoblotting
with a Ded1 antibody [49], and expression levels
of the ectopic DDX3X and Ded1 were also similar
(Fig. S12b).
The DDX3X mutations associated with pediatric
cancer [2] (and personal communication, Jinghui
Zhang and James Downing) were tested for com-
plementation of the ded1-1D5 temperature-sensitive
growth defect (Fig. S13a). An ATPase-defective
Walker-A DDX3Xmutant, K230A, was also tested as
an internal control. The mutants A222P, K230A
(Walker-A), G302V, G325E, and P568L all exhibited
growth defects at restrictive temperature. The
severity of the growth defect was assessed by
using serial dilution assays and by plating cells at an
intermediate temperature of 33 °C (Fig. S13b). This
analysis revealed that K230A (Walker-A) was the
most defective mutant and negatively impacted
growth of ded1-1D5 cells even at the permissive
temperature of 25 °C. G302V, G325E, and A222P
exhibited intermediate defects, and P568L was also
somewhat impaired.
All DDX3X proteins were expressed at slightly
lower levels at the restrictive temperature, with a
more marked reduction in expression of the non-
complementing mutants (Fig. S13c). To address
the possibility that reduced protein level contribut-
ed to the phenotype, we transformed a cold-sensi-
tive ded1 mutant strain, ded1-61 [41], and found
that the same set of mutants failed to complement
for growth at restrictive cold temperature (25 °C)
(Fig. 5a). Under these conditions, however, protein
levels for all DDX3X proteins were elevated,
indicating that cell growth differences are not
caused by altered DDX3X expression levels
(Fig. 5b). Thus, we differentiate the cancer-asso-
ciated DDX3X mutants into two classes. Those that
can functionally replace Ded1 are referred to as
“functional mutants” (T275M, R351W, L353F,
D354V, and M370R), and “non-complementing
mutants” are those that cannot functionally replace
Ded1 in ded1 thermosensitive mutants at restric-
tive temperature (A222P, G302V, G325E, and
P568L).
Functional DDX3X facilitates expression of
cyclin Cig2 protein
The ded1-1D5 mutation is associated with
decreased overall protein translation at the non-
permissive temperature [41], and translation of the
cyclins Cig2 and Cdc13 is especially sensitive [41].
We monitored levels of Cig2-3×HA protein in the
different strains.Cig2 expression levelswere impaired
after 2.5 h of growth at 36 °C inded1-1D5mutant cellsbut were unaffected in cells expressing wild-type
Ded1 or DDX3X (Fig. S12c). The non-complementing
mutants A222P, G302V, and G325E all showed
1790 Cancer-Associated Mutants of DDX3Xreduced Cig2 levels at 36 °C when compared to
wild-type DDX3X (Fig. S13c). The P568L mutant,
which exhibited only very minor defects at the
semi-permissive temperature, did not show signifi-
cantly different Cig2 expression levels at 25 °C versus
36 °C. Similar results were observed in ded1-61 cells
following shift to 20 °C for 3 h (Fig. 5b). The
decreased Cig2 protein level in non-complementing
mutants is not due to a transcriptional defect because
the defective mutants exhibited high cig2+ transcript
levels (Fig. 5c and Fig. S13d) when measured by
quantitative real-time PCR after 2.5 h growth at
restrictive temperature. The elevation in cig2+ tran-
scriptsmay bedue toarrest of the non-complementing
mutant cells at G1 phase of the cell cycle when cig2+
is maximally transcribed.Discussion
DDX3X belongs to the DEAD-box family of
helicases, which hydrolyze ATP and remodel RNA
secondary structure through the combined activities
of several conserved helicase motif residues on two
tandem RecA-like domains. Here we show that, in
addition to the canonical DEAD-box helicase motifs,
DDX3X also uses an N-terminal ABL (residues 135–
168) to interact with ATP. While motif I, motif II, and
the Q-motif interact with Mg/ATP with well-defined
characteristic interactions [8], the ABL does not
seem to use a single set of specific interactions. The
dynamic nature of ABL:ATP interaction is shown by
the high B-factors in the ABL and the difficulty in
assigning the sequence registry in the ABL region.
Although dynamic, the ABL clearly interacts with
ATP as shown by the CSP and ITC experiments,
and the ABL plays a decisive role in RNA-stimulated
ATPase activity. This role is specific to DDX3X and
its close relatives because most DEAD-box heli-
cases do not possess this ABL. The ABL is therefore
not intrinsically required to catalyze ATP hydrolysis.
Instead, we suggest that the ABL is involved in
stimulating ATP hydrolysis by preferred RNA sub-
strates. Consistent with this role, the ABL shows
CSP upon addition of dsRNA, suggesting that the
ABL can sense the presence of bound dsRNA. An
intriguing possibility is that the ABL is normally
dynamic but becomes well structured when DDX3X
binds a specific form of RNA, thus facilitating ATP
hydrolysis. Consistent with this hypothesis, the
crystal structure of DmVasa has RNA bound [30]
and shows a well-ordered ABL.
The ATPase activity of DDX3X is stimulated by a
hybrid dsRNA/ssRNA substrate, but not by blunt
dsRNA or ssRNA, suggesting that DDX3X is
specialized for specific RNA structures. The specific
biological RNA substrates of DDX3X are not known,
and it is possible that the synthetic dsRNA/ssRNA
substrate of our assay is not the optimal substrate forDDX3X ATPase activity. Nevertheless, our CSP
experiments show that D1 has specificity for dsRNA
and that binding involves residues G302 and G325
in canonical RNA-binding sequence motifs [8]. The
CSP experiments also indicate that D1 interacts
nonspecifically with ssRNA. We therefore suggest
that the RNA-bound species leading to ATPase
stimulation has dsRNA bound at G302 and G325
(motifs Ib and Ic) as shown in our dsRNA binding
model (Fig. 4) and ssRNA interacting at a region that
is yet to be identified. Possible candidates for ssRNA
interaction include motifs IV, IVa, and V in D2,
canonical RNA-binding motifs [8] in a domain that we
were unable to examine by NMR.
Consistent with a strong role in acting on cellular
RNA targets, the medulloblastoma mutants G302V
and G325E are severely defective for RNA-stimu-
lated ATPase activity and cannot functionally com-
plement Ded1 in fission yeast. Although ATP
hydrolysis is clearly required for the functional
complementation based upon the profound growth
defect of the DDX3X K230A (Walker-A/motif I)
ATPase-defective mutant, none of the residues
within D1 that are mutated in medulloblastoma
shows significant interaction with ATP-γS in our
NMR experiments. Instead, the ATPase defects of
the G302V and the G325E mutants likely arise from
severely compromised RNA stimulation of the
ATPase activity. Consistent with this model, both
residues are clearly shifted upon binding dsRNA
(Fig. 3), and both are in canonical RNA-binding
DEAD-box helicase motifs (motifs Ib and Ic). The
unperturbed affinity of G325E for dsRNA in EMSAs
indicates that RNA binding alone does not dictate
ATPase stimulation and that other critical features
must be elucidated. Our dsRNA binding model
(Fig. 4) suggests that G302 and G325 bind one
strand of dsRNA, and the region described as motif
IIa [32] binds in the minor groove, perhaps also
binding the complementary strand. In this model, the
medulloblastoma mutants R351W, L353F, and
D354V could have potential roles in sequence
specificity. Based on this model, DDX3X interaction
with the RNAminor groove by motif IIa is likely not as
essential as the set of interactions with the first
strand by motifs Ib and Ic. The motif IIa mutants
L353F and D354V exhibit only limited RNA binding
and ATPase defects and can functionally comple-
ment Ded1 while the G302V and G325E mutants
have severe RNA-stimulated ATPase defects and
cannot functionally complement SpDed1.
DDX3X, like Ded1, has been implicated in the
positive regulation of translation of transcripts with
complex UTR sequences, including G1/S cyclins.
We propose that a subset of the DDX3X mutants
identified in pediatric medulloblastomas have
reduced RNA-dependent ATPase activity that
impairs translation of critical cellular regulators
and contributes to the development of the disease.
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show that expression of Cig2 is disrupted by
mutants of DDX3X with highly reduced RNA-sti-
mulated ATPase activity. It has been demonstrated
that Ded1 is required for the effective translation of
Cig2, perhaps playing a role in remodeling the long
structured 5′-UTR of the transcript [41]. If the
5′-UTR is shortened, this requirement is reduced
[41]. Complementation by wild-type and mutant
DDX3X produces phenotypes that are fully consis-
tent with Cig2 5′-UTR processing in a ded1
temperature-sensitive strain. Similarly, in human
cells, cyclin E1 levels are greatly reduced upon
knockdown of DDX3X but are restored when the
5′-UTR is exchanged for that of cyclin D1, which is
unaffected by DDX3X knockdown [38]. The 5′-UTR
of human cyclin E1 is 82.5% GC and is also
predicted to have a highly stable secondary
structure [38]. Several retroviruses also depend
on cellular DDX3XDed1 for the translation of viral
transcripts. HIV-1 is dependent on DDX3X for
translation, and hence, DDX3X has been studied
as a potential anti-HIV drug target [50,51]. Similar-
ities between some of the viral RNAs and human
transcripts that are regulated by DDX3X are the
presence of long UTR sequences with secondary
structure and a very high GC content that stabilizes
this secondary structure. DDX3X has been report-
ed to reduce the secondary structure of retroviral
UTRs, allowing the 43S ribosome to bind for
translation [37]. We suggest that DDX3X is needed
to process long structured 5′-UTR sequences and
that this activity is lost in the G302V and G325E
mutants. An intriguing possibility is that DDX3X
acts upon the 5′-UTRs of multiple mRNAs to
correctly balance levels of growth promoting proteins
with tumor suppressors. A mutation that decreases
DDX3X activity could promote tumorigenesis by
preventing translation of tumor suppressors while a
mutation that enhances DDX3X activity could pro-
mote tumorigenesis through excessive translation of
growth promoting proteins. It will be interesting to
determine whether select DDX3X mutants contribute
to human medulloblastoma through translational
control of such cell cycle regulators.Experimental Procedures
Media and chemicals
Fission yeast were maintained on rich media (YES),
unless nutritional selection was required for mainte-
nance o f t h e LEU2 ma r k e d p l a sm i d
(pREP41-3×V5 series), when cells were grown
on PMG media with appropriate supplements [52].
All chemicals were purchased from Sigma unless
otherwise indicated.Cloning andmutagenesis for plasmid construction
Escherichia coli expression plasmids are as
follows: the wild-type hsDDX3X gene was ob-
tained as an IMAGE clone from Open Biosys-
tems. The full gene was amplified by PCR using
primers flanked by EcoRI and XhoI restriction
sites. The PCR product was digested with EcoRI/
XhoI and ligated into an EcoRI/XhoI-digested,
phosphatase-treated pET-28a vector. The T7 tag
was removed from the construct by mutagenesis
to generate an expression construct with a
thrombin-cleavable His6 tag. Expression plas-
mids for N- or C-terminal deletions were pre-
pared by PCR of the entire plasmid, excluding
the region to be deleted, with phosphorylated
primers followed by circularization with ligase,
producing constructs for His6-DDX3X (135–582)
(pLE193), His6-DDX3X (168–582) (LE194), His6-
DDX3X (135–407) (pLE231), and His6-DDX3X
(408–582) (pLE235). Mutations were similarly
introduced with phosphorylated mutagenic primers
to generate His6-DDX3X (135–582) G302V
(pLE210) , His6-DDX3X (135–582) L353F
(pLE224), His6-DDX3X (135–582) G325E
(pLE228), and His6-DDX3X (135–582) D354V
(pLE230). Sequences were verified by the Hartwell
Center DNA Sequencing Facility (St. Jude Children's
Research Hospital).
S. pombe expression plasmids are as follows:
ded1+ was amplified from S. pombe genomic DNA
using primers bearing SalI sites and 15 bases of
homology with the vector at the 5′ and 3′ ends of
the gene. This PCR fragment was cloned into a
LEU2 marked fission yeast expression vector
carrying an N terminal 3×V5 epitope tag under
control of a mid-strength nmt1 promoter
[pREP41-V5 (JP1340), kind gift from P. Bjerling],
which was linearized with SalI downstream of the
epitope tag. Cloning was performed using InFu-
sion HD (Clontech): 50 ng each of vector and
insert were incubated with InFusion mix at 50 °C
for 15 min and on ice for 15 min, prior to
transformation of Stellar-competent cells (Clon-
tech). Clones were screened by PCR, and full
sequencing of the ded1 insert was performed.
Construction of plasmids expressing full-length,
wild-type DDX3X was performed similarly, using a
cloned DDX3X cDNA (kind gift from J. P. Taylor)
as template. Vectors containing mutant DDX3X
were produced through PCR mutagenesis of the
JP2104 DDX3X construct using Phusion high-
fidelity DNA polymerase (Thermo F-553). The
following are the mutations made: A222P,
K230A, T275M, G302V, G325E, R351W, L353F,
D354V, M370R, and P568L. Sequencing was
performed on the entire DDX3X gene of these
plasmids to verify that only the required mutation
was created.
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Each construct was freshly transformed into
BL21(DE3)-RIPL (Stratagene) chemically competent
cells and grown overnight in a 100-ml starter culture
containing 30 mg/l kanamycin and 8 g/l glucose.
Large-scale cultures were prepared by inoculating
10 ml of starter culture per liter of fresh LB media
containing 30 mg/l kanamycin and 8 g/l glucose. The
cultures were shaken at 200 rpm at 37 °C and
induced at 18 °C by 0.5 mM IPTG once the optical
density reached 0.7–0.8. After growing overnight,
cells were harvested by centrifugation for 15 min in an
SLC-6000 rotor at 3200 rcf. The cells were resus-
pended in lysis buffer [50 mM Tris (pH 8.3), 250 mM
NaCl, 10% glycerol, 2 mM β-mercaptoethanol (BME),
and Roche complete ethylenediaminetetraacetic-a-
cid-free protease inhibitor tablets] and lysed using a
microfluidizer. The soluble fraction was isolated after
centrifugation in an SLC-1500 rotor (13,000 rpm in a
Sorvall RC-6+ centrifuge) for 45 min. For samples
used in biochemical assays, sodium chloride was
added to a final concentration of 1 M, and then nucleic
acids were precipitated by adding 10% polyethylenei-
mine/10% hydrochloric acid to a final concentration
of 0.3%. This solution was centrifuged at 2900 rcf for
15 min in a benchtop centrifuge, and the superna-
tant was collected. Ammonium sulfate was added to
70% saturation, and the precipitate was isolated by
centrifugation for 1 h at 13,000 rpm in an SLC-1500
rotor in a Sorvall RC-6+ centrifuge. The pellet was
resuspended in buffer NBB [50 mM Tris (pH 8.3),
500 mM NaCl, 25 mM imidazole, 10% glycerol, and
2 mMBME] and bound batchwise to Qiagen Ni-NTA
agarose. After 8 washings of the Ni-NTA agarose
with NBB, the protein was eluted in a single step with
50 mM Tris (pH 8.3), 500 mM NaCl, 10% glycerol,
2 mM BME, and 250 mM imidazole. The proteins
were further purified by size-exclusion chromatog-
raphy with a Superdex 26/60 column. For crystalli-
zation samples, the final gel-filtration buffer was
20 mM Hepes (pH 7.6), 150 mM KCl, 5 mM DTT,
and 5 mM MgCl2. Other samples of DDX3X (135–
582) were purified in 20 mM Hepes (pH 7.6),
200 mM NaCl, and 2 mM DTT. The DDX3X (168–
582) sample was purified in 20 mM Hepes
(pH 7.6), 500 mM NaCl, 10% glycerol, and 2 mM
tris(2-carboxyethyl)phosphine. Protein concentra-
tions were determined by absorbance at 280 nm
(ε135–582 = 38,850, ε135–407 = 20,400, and
ε168–582 = 31,860). Extinction coefficients were
calculated using the ProtParam tool on the ExPasy
server‡.
Crystallization, data collection, structure solution,
model building, and refinement
For DDX3X (135–582) D354V, the protein was
co-concentrated with 2.5 mM ADP and 25 mMMgCl2 to 15 mg/ml. Crystals grew when mixed 1:1
with 1.66 M NaH2PO4/0.240 M K2HPO4 at 18 °C.
Crystals were quickly passed through a 1:3 solution
of ethylene glycol in the crystallization well solution
and flash frozen in liquid nitrogen. Data were
collected at Southeast Regional Collaborative Ac-
cess Team (SER-CAT) beamline 22-ID at the
Advanced Photon Source at Argonne National
Laboratory at 1.0 Å wavelength. Data were inte-
grated and scaled with the HKL-2000 package [53]
to 3.2 Å resolution. Initial phases were determined
by molecular replacement by the program Phaser
[54] that placed one copy of the individual D1 and D2
domains of HsDDX3X (PDB ID: 2I4I) [29]. The
model was manually improved with Coot [55] and
refined at various stages with CNS [56,57] and
REFMAC5 [58]. The final refinement was carried out
with CNS. Figures were prepared with the program
PyMOL [59] and Coot [55]. Although DDX3X (135–
582) D354V was crystallized in the presence of
Mg2+ and ADP, electron density was not observed
for Mg2+.
For DDX3X (135–407), the protein was initially
concentrated to 5 mg/ml when it started precipitat-
i ng . Add i t i on o f MgCl2 and AMP-PNP,
AMP-PNP + U10 RNA, or ATP-γS improved the
solubility and permitted higher concentrations.
Each sample was screened for crystallization on
an Art Robbins Phoenix Robot with commercial kits
from Qiagen and Hampton Research, which
produced lead crystals for the AMP-PNP-treated
samples. A fresh sample was co-concentrated with
10 mM AMP-PNP and 20 mM DTT to a final
concentration of 15 mg/ml and filtered. Single
crystals grew in a few days when mixed 1:1 with
50 mM Hepes (pH 7.6) and 7% polyethylene glycol
3350 and incubated at 18 °C. Crystals were quickly
passed through a 1:3 solution of ethylene glycol in
the crystallization well solution and flash frozen in
liquid nitrogen. Data were collected at SER-CAT
beamline 22-ID at the Advanced Photon Source at
Argonne National Laboratory. Data were collected
at 1.0 Å wavelength in 0.5° oscillations for a total of
125° of crystal rotation. Data were integrated and
scaled with the HKL-2000 package [53] to 2.3 Å
resolution. Initial phases were determined by
molecular replacement by the program Phaser
[54] that placed three copies of the N-terminal
domain of HsDDX3X (PDB ID: 2I4I) [29]. The
model was refined at various stages with CNS
[56,57] and REFMAC5 [58]. The final refinement
was carried out with CNS using three NCS restraint
groups for the three copies. Figures were prepared
with the program PyMOL [59] and Coot [55].
Although DDX3X D1 was crystallized in the pres-
ence of Mg2+ and AMP-PNP, electron density was
not observed for Mg2+ or for the γ-phosphate. The
nucleotide has been modeled as ADP in the final
refinement.
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ATPase experiments were all performed at 30 °C
in 50 μl reactions containing 40 mM Hepes (pH 7.6),
35 mM KCl, 2 mM DTT, 5 mM MgCl2, and 2 mM
ATP. Reactions with added RNA included 1 μg of one
of the following sequences: UUUUUUUUUU (U10),
GGGCGGGCCCGCCC (blunt dsRNA; palindromic
14-mer), or UUUUUUUUUUUUUUUUUUUUGG
CGGCCGCC (palindromic 10-mer dsRNA with
20-mer 5′-overhangs). Initial experiments to determine
anRNA substrate that would stimulate ATPase activity
were performed for 30 min with 3 μM protein in
triplicate. Time-course and concentration-dependent
experiments were performed with the palindromic
10-mer dsRNA with 20-mer 5′-overhangs. Time-
course experiments were performed in duplicate with
3 μM final concentration of the indicated protein.
Protein-concentration-dependent experiments were
performed in duplicate, by incubating protein concen-
trations ranging from 0 to 3 μM for 30 min. Released
phosphate was quantified with the Biomol Green
(ENZO Life Sciences) detection kit. Standard curve
reactions were prepared with NaH2PO4 as a phos-
phate standard in identical buffer conditions. Graph-
Pad Prism was used to calculate released phosphate
by linear regression and for plotting of results.
Electromobility shift assay
A palindromic 14-mer RNA, GGGCGGGCCC
GCCC, previously shown to bind to the DEAD-box
helicaseMss116p, was obtained commercially (Sigma
Aldrich) with a 3′-fluorescein modification. Protein
samples were dialyzed into 50 mM Tris (pH 7.5),
125 mMKCl, 5 mMDTT, 10 mMMgCl2, 10%glycerol,
and 0.05% Tween-20 and adjusted to 3.2 mg/ml as
determined by absorbance at 280 nm on a NanoDrop
spectrophotometer. Binding reactions contained a total
volume of 18 μl of protein/dialysis buffer, ranging from
0 to 55 μM final protein concentration, and 2 μl of
fluorescently labeled RNA (40 nM final concentration).
Wild-type DDX3X (135–582) was also titrated in the
presence of 1 mM ATP-γS. After incubating at 25 °C
for 30 min, 5 μl of 40% sucrose was added, and 20 μl
was loaded in a 4–20% gradient native TBE polyacryl-
amide gel (Bio-Rad) and run for 1 h at 150 V in 1× TBE
buffer. The gel was then imagedwith a SybrGreen filter
for 2 min on a FujiFilm LAS4000. Three independent
titrations were performed for each sample.
Isothermal titration calorimetry
Thermodynamic parameters for the interaction of
DDX3X-with-ABL (135–582) and DDX3X-No-ABL
(168–582) with ATP analog were measured with a
MicroCal auto-iTC 200 (GE Healthcare). Protein
samples were exchanged into 20 mM Hepes
(pH 7.6), 150 mM KCl, 2 mM tris(2-carboxyethyl)phosphine, and 5% or 10% glycerol prior to the
experiments. Titrations were performed by first
injecting 0.5 μl of 2.5 mM ATP analog (ATP-γS)
into a solution of 90 μM DDX3X-with-ABL or
DDX3X-No-ABL, followed by additional 2-μl injec-
tions. Experiments were carried out at 25 °C. Results
were analyzed using Origin software (OriginLab)
provided by MicroCal. Binding constants (Kd) were
calculated from the average of three individual
experiments by fitting the data to a single-site binding
model using a nonlinear least-squares fitting algorithm.
Strains
Ded1 mutant strains are described in Ref. [41].
S. pombe: the ded1-1D5 mutant allele was
sequenced and found to contain two point muta-
tions, S282F and R285C. The ded1-61 mutant
allele contained a P263L mutation. The ded1-61
cig2-3×HA strain (PY7803) was used for all
ded1-61 analyses. The leu1-32 mutation was
introduced into the ded1-1D5 cig2-3×HA strain
(PY 7885) prior to transformation.
Plating assays
For the simple temperature sensitivity plating
assay, ded1-1D5 strains were streaked onto PMG
agar lacking leucine to maintain the plasmid and
were incubated for 2–3 days at either 25 °C or 36 °C
before being photographed. For the serial dilution
growth assay, ded1-1D5 cells were grown at 25 °C
and ded1-61 cells were grown at 32 °C to a density of
5 × 106 cells/ml in PMG−Leumedia.Wemade 5-fold
serial dilutions and spotted them onto PMG −Leu agar
plates such that 1.2 × 104 cells were contained in the
first spot. Plates were incubated at 25 °C or 33 °C for
5–7 days.
Protein extracts and Western blotting
Cells were grown overnight at 25 °C in PMG −Leu
to a density of 5.0 × 106 cells/ml. Protein extracts
were made by bead beating cells in 2× SDS sample
buffer with chilled glass beads for 3 min and heating
to 90 °C for 2 min. The samples were spun out at
13,000 rpm for 10 min and the supernatant was
collected. Extracts were run on NuPage 4–12%
Bis-Tris minigels (Invitrogen) in NuPage Mops buffer
(Invitrogen) and transferred to Protran membrane
(GE Life Science). Western blotting was performed
using the following mouse monoclonal antibodies:
anti-V5 antibody (AbD Serotec MCA1360) and
anti-tubulin antibody (kind gift from K. Gull) at
dilutions of 1:2000 in phosphate-buffered sa-
line + 0.2% Tween for 1 h at room temperature.
Rat monoclonal anti-HA 3F10 antibody (Roche
1867423) was used at a dilution of 1:500 overnight
at 4 °C. Rabbit polyclonal anti-Ded1p antibody (kind
1794 Cancer-Associated Mutants of DDX3Xgift from N. Walworth) was used at a dilution of
1:50,000 overnight at 4 °C. Incubations were per-
formed with secondary antibodies [anti-mouse IgG
peroxidase (Sigma A4416), anti-rabbit IgG peroxi-
dase (Sigma A6154), and anti-rat IgG peroxidase
(Sigma SAB3700595)] at dilutions of 1:5000 in 3%
milk phosphate-buffered saline + 0.2% Tween for
1 h at room temperature. Detection was performed
using Pierce ECL substrate and exposure to
Hyperfilm (GE Life Sciences).
Temperature shift assays on ded1-1D5 cultures
were performed by growing cells in PMG −Leu to a
density of ~4.0 × 106 cells/ml at 25 °C. The culture
was split, and one culture was kept at 25 °C while
the other was shifted to 36 °C for 3 h. For ded1-61
cultures, cells were grown to a density of ~4.0 × 106
cells/ml at 32 °C and were split and cultured at 20 °C
or 36 °C for 3 h. Total cell extracts were made as
described above.
Transcript analyses
For ded1-1D5, cells were grown to a density of
~4.0 × 106 cells/ml at 25 °C in PMG −Leu and
were split and grown at 25 °C or 36 °C for 2.5 h.
For ded1-61 cultures, cells were grown at 32 °C
prior to splitting and growing at 20 °C or 36 °C
for 3 h. Random priming of total cellular RNA was
used to prepare cDNA as described previously [60].
Quantitative real-time PCR was performed to measure
t r a n s c r i p t l e v e l s o f c i g 2 + ( JPO 2990
TTTGTTTAATGCCCGAAACC and JPO 2991
TGCTAGCGATGAGAAGAGCA) and adh1+ as the
euchromatic control (JPO 793 AACGTCAAGTTC-
GAGGAAGTCC and JPO 794 AGAGCGTG-
TAAATCGGTGTGG). Real-time PCR was performed
using an Eppendorf Mastercycler epRealplexmachine
and Quantifast Sybr green (Qiagen). cig2 transcript
levels were normalized to adh1, and results represent
the mean of two biological replicates. The linear range
of amplification for each set of primerswas verified, and
experiments were performed within this range. The
ΔΔCt method was used for the analysis of transcript
levels.
Accession numbers
Coordinates and structure factors have been
deposited in the Protein Data Bank with accession
numbers 4PX9 and 4PXA.Acknowledgements
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